Skip to main content

Advertisement

Log in

Paced Respiration for Vasomotor and Other Menopausal Symptoms: A Randomized, Controlled Trial

  • Original Research
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

ABSTRACT

BACKGROUND

Paced respiration has been internationally recommended for vasomotor symptom management, despite limited empirical evidence.

OBJECTIVE

To evaluate efficacy of a paced respiration intervention against breathing control and usual care control for vasomotor and other menopausal symptoms.

DESIGN

A 16-week, 3-group, partially blinded, controlled trial with 2:2:1 randomization and stratification by group (breast cancer, no cancer), in a Midwestern city and surrounding area.

PARTICIPANTS

Two hundred and eighteen randomized women (96 breast cancer survivors, 122 menopausal women without cancer), recruited through community mailings and registries (29 % minority).

INTERVENTIONS

Training, home practice support, and instructions to use the breathing at the time of each hot flash were delivered via compact disc with printed booklet (paced respiration intervention) or digital videodisc with printed booklet (fast shallow breathing control). Usual care control received a letter regarding group assignment.

MAIN MEASURES

Hot flash frequency, severity, and bother (primary); hot flash interference in daily life, perceived control over hot flashes, and mood and sleep disturbances (secondary). Intervention performance, adherence, and adverse events were assessed.

KEY RESULTS

There were no significant group differences for primary outcomes at 8-weeks or 16-weeks post-randomization. Most intervention participants did not achieve 50 % reduction in vasomotor symptoms, despite demonstrated ability to correctly do paced respiration and daily practice. Statistically significant differences in secondary outcomes at 8 and 16 weeks were small, not likely to be clinically relevant, and as likely to favor intervention as breathing control.

CONCLUSIONS

Paced respiration is unlikely to provide clinical benefit for vasomotor or other menopausal symptoms in breast cancer survivors or menopausal women without cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1.
Figure 2.

Similar content being viewed by others

REFERENCES

  1. Rada G, Capurro D, Pantoja T, Corbalan J, Moreno G, Letelier LM, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010;(9):CD004923.

  2. Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin re-uptake inhibitor paroxetine. J Natl Cancer Inst. 2003;95(23):1758–64.

    Article  PubMed  CAS  Google Scholar 

  3. North American Menopause Society N. Menopause Practice: a Clinician’s Guide. 4th ed. Mayfield Heights: North American Menopause Society; 2010.

    Google Scholar 

  4. North American Menopause Society N. The Menopause Guidebook. 7th ed. Mayfield Heights: North American Menopause Society; 2012.

    Google Scholar 

  5. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol. 1992;167(2):436–9.

    PubMed  CAS  Google Scholar 

  6. Freedman RR, Woodward S, Brown B, Javiad JI, Pandey GN. Biochemical and thermoregulatory effects of behavioral treatment for menopausal hot flashes. Menopause. 1995;2(4):211–8.

    Article  Google Scholar 

  7. Germaine LM, Freedman RR. Behavioral treatment of menopausal hot flashes: evaluation by objective methods. J Consult Clin Psychol. 1984;52(6):1072–9.

    Article  PubMed  CAS  Google Scholar 

  8. Butt DA, Deng LYR, Lewis JE, Lock M. Minimal decrease in hot flashes desired by postmenopausal women in family practice. Menopause. 2007;14(2):203–7.

    Article  PubMed  Google Scholar 

  9. Carpenter JS, Storniolo AM, Johns S, Monahan PO, Azzouz F, Elam JL, et al. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist. 2007;12(1):124–35.

    Article  PubMed  CAS  Google Scholar 

  10. Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support Care Cancer. 2009;17(10):1301–9.

    Article  PubMed  Google Scholar 

  11. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst. 2000;92(13):1054–64.

    Article  PubMed  CAS  Google Scholar 

  12. Mann E, Smith M, Hellier J, Hunter MS. A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol. BMC Cancer. 2011;11:44.

    Article  PubMed  Google Scholar 

  13. Carpenter JS, Neal JG, Payne J, Kimmick G, Storniolo AM. Cognitive–behavioral intervention for hot flashes. Oncol Nurs Forum. 2007;34(1):E1–8.

    Article  Google Scholar 

  14. Carpenter JS. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manag. 2001;22(6):979–89.

    Article  CAS  Google Scholar 

  15. Reynolds F. Relationships between catastrophic thoughts, perceived control and distress during menopausal hot flushes: exploring the correlates of a questionnaire measure. Maturitas. 2000;36(2):113–22.

    Article  PubMed  CAS  Google Scholar 

  16. Reynolds FA. Perceived control over menopausal hot flushes: exploring the correlates of a standardised measure. Maturitas. 1997;27(3):215–21.

    Article  PubMed  CAS  Google Scholar 

  17. Koller M, Kussman J, Lorenz W, Jenkins M, Voss M, Arens E, et al. Symptom reporting in cancer patients: the role of negative affect and experienced social stigma. Cancer. 1996;77(5):983–95.

    Article  PubMed  CAS  Google Scholar 

  18. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54(6):1063–70.

    Article  PubMed  CAS  Google Scholar 

  19. Curran SL, Andrykowski M, Studts JL. Short form of the Profile of Mood States (POMS-SF): psychometric information. Psychol Assess. 1995;7(1):80–3.

    Article  Google Scholar 

  20. McNair DM, Lorr M, Droppelman LF. POMS Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service; 1971.

    Google Scholar 

  21. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.

    Article  PubMed  CAS  Google Scholar 

  22. Taffe J, Dennerstein L. Menstrual diary data and menopausal transition: methodologic issues. Acta Obstet Gynecol Scand. 2002;81(7):588–94.

    Article  PubMed  Google Scholar 

  23. Carpenter JS, Newton KM, Sternfeld B, Joffe H, Reed SD, Ensrud KE, et al. Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network. Menopause. 2012;19(6):664–71.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Contributors

There are no additional contributors who meet criteria for authorship.

Funders

The project described was supported by Award Number 5 R01 CA132927 from the National Cancer Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funding agency had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.

Prior Presentations

None.

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Janet S. Carpenter PhD, RN, FAAN.

Additional information

Trial registration: http://clinicaltrials.gov, NCT00819182

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Table 3

(PDF 23.6 kb)

Supplemental Figure 2

(PDF 24.4 kb)

Supplemental Figure 3

(PDF 310 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carpenter, J.S., Burns, D.S., Wu, J. et al. Paced Respiration for Vasomotor and Other Menopausal Symptoms: A Randomized, Controlled Trial. J GEN INTERN MED 28, 193–200 (2013). https://doi.org/10.1007/s11606-012-2202-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-012-2202-6

KEY WORDS

Navigation